Photoacoustic tomography (PAT) is a rapidly emerging non-invasive imaging technology that integrates the merits of high optical contrast with high ultrasound resolution. The ability to quantitatively and non-invasively image nanoparticles has important implications for the development of nanoparticles as in vivo cancer diagnostic and therapeutic agents. In this study, the ability of systemically administered poly(ethylene glycol)-coated (PEGylated) gold nanoparticles as a contrast agent for in vivo tumor imaging with PAT has been evaluated. We demonstrate that gold nanoparticles (20 and 50 nm) have high photoacoustic contrast as compared to mouse tissue ex vivo. Gold nanoparticles can be visualized in mice in vivo following subcutaneous administration using PAT. Following intravenous administration of PEGylated gold nanoparticles to tumor-bearing mice, accumulation of gold nanoparticles in tumors can be effectively imaged with PAT. With gold nanoparticles as a contrast agent, PAT has important potential applications in the image guided therapy of superficial tumors such as breast cancer, melanoma and Merkel cell carcinoma.
Introduction
Gold nanoparticles belong to a versatile and biocompatible class of nanomaterials with significant therapeutic potential [1] . Due to their well-established surface conjugation chemistries, gold nanoparticles may be linked to specific cancer ligands for tumor targeting and therapeutics [2] . Systemically administered tumor necrosis factor conjugated 5 QZ and NI contributed equally to this work. Portions of this work were presented at: Biomedical Optics (BIOMED), St Petersburg, Florida. March 16, 2008 . 6 Authors to whom any correspondence should be addressed.
gold nanoparticles improve survival rates in tumor-bearing mice [3] . Gold nanoparticles have been used experimentally to enhance sensitivity to external beam radiation therapy [4] and their photo-thermal properties have been used for lightmediated remote drug release [5] . Gold is currently approved by the United States Food and Drug Administration for use in humans with rheumatoid arthritis. Gold nanoparticles have been shown to be non-toxic to human cells [6] and are currently undergoing initial investigation in clinical cancer trials in humans with advanced malignancy (US National Cancer Institute-06-C-0167). One of the greatest limitations of using gold nanomaterials for biomedical applications is the inherent difficulty in monitoring them non-invasively, in vivo or during histological analysis, and it is an important area of research. Surface-enhanced Raman scattering, for instance, has recently been used for detecting gold nanoparticles under in vivo conditions [7] . Development of this and other technologies for in vivo applications is essential for the continued development of gold nanoparticles for novel theranostics applications.
Photoacoustic tomography (PAT) is a non-ionizing, noninvasive imaging modality which combines the advantages of highly sensitive optical imaging and high ultrasound resolution [8] .
PAT is highly sensitive to absorption characteristics of the sample and uses pulsed laser light for illumination of the sample. Absorption of light leads to transient variations in temperature resulting in the generation of acoustic signals which are measured [9] and converted into an image of the object. PAT with finite element reconstruction has been used to image millimeter-sized nanoparticles containing objects in vitro with high contrast resolution [10] . Another important aspect of PAT images is that they can be reconstructed in a quantitative manner [11] . Gold and gold-speckled silica nanoparticles have been used as a contrast agent for imaging with PAT in vitro [9, 12] . PAT has also been used for in vivo imaging of cerebral vasculature in mice using indocyanine green [13] , gold nanocages [14] and nanoshells [15] as contrast agents. In this study, we report the PAT contrast generating ability of the gold nanoparticles in vivo and ex vivo, and also demonstrate the ability to detect these non-invasively in a mouse model of breast tumors. The ability to image gold nanoparticles in vivo has important implications for developing these biocompatible nanoparticles for cancer diagnostic and therapeutic applications especially for superficial tumors such as breast cancer, melanoma and Merkel cell carcinoma.
Methods and materials

Gold nanoparticles
Gold nanoparticles were synthesized by citrate reduction of auric chloride (HAuCl 4 ) following the procedure of Frens [16] . The various factors controlling the size, size distribution and shape of the gold nanoparticles in the citrate reduction method have been studied in detail [17] [18] [19] . In this report the synthesis of different sizes of gold nanoparticles has been achieved by changing the concentration of the citrate with respect to the auric chloride [17] . Briefly, for the synthesis of 50 nm gold nanoparticles, 2.5 ml of 50 mM auric chloride was added to 1 litre nanopure water and the solution was brought to a boil. 2.5 ml of 0.034 M Na 3 citrate was rapidly added to the boiling solution. The color of the solution changed from yellow to dark gray and finally to red, after which the solution was allowed to boil for an additional 15 min. The solution was then allowed to cool to room temperature. The particles were separated by centrifugation and washed twice with nanopure water to remove excess citrate ions from the solution. To minimize the aggregation of the particles in this process, the centrifugation step was carried at low speeds that led to a higher concentration (concentration gradient) of gold nanoparticles towards the bottom end of the centrifugation tube and prevented aggregation or pellet formation. The synthesis of 20 nm gold nanoparticles was carried out in a similar method by increasing the molar ratio of Na 3 citrate to 3.4 times with respect to auric chloride. The particle size characterization was done by CPS disc centrifugation and TEM.
Gold nanoparticles were modified with PEG5000-thiol following the procedure of Bergen et al [20] .
The surface ligand density on gold nanoparticles, desirable for high stability in physiological salt concentrations, has been previously established [21] and used successfully in in vivo studies [20] . Briefly, ∼30 mg of the gold particles were dispersed in previously degassed water by sonication. The particles were then reacted with a requisite amount of PEGthiol (to obtain ∼4-5 PEG molecules nm −2 gold surface area) at 25
• C for approximately 12 h. The particles were separated by centrifugation and washed thrice with PBS buffer, maintaining sterile conditions.
Photoacoustic tomography
For all experiments, a mechanical scanning photoacoustic system with a single acoustic transducer to collect the acoustic signals was utilized. A pulsed Nd:YAG laser (Altos, Bozeman, MT) working at 532 nm with 4 ns pulse duration and 360 mJ maximum pulse power acted as the light source. The diameter of the laser beam was expanded to 30 mm by a lens. The light power was measured as 15 mJ cm −2 at the surface of the phantom/mouse abdomen, which was lower than the maximum permissible exposure to a 532 nm laser beam which, for skin, is 20 mJ cm −2 . An immersion acoustic transducer with 1 MHz nominal frequency (Valpey Fisher, Hopkinton, MA) was driven by a motorized rotator to receive acoustic signals over 270
• for in vivo cases and 360
• for phantom ex vivo cases at an interval of 3
• and thus a total of 90 and 120 measurements were performed for one planar scanning, respectively. The acoustic transducer has a diameter of 6 mm and it can cover a 9 mm thick scanning plane at a distance of 35 mm, which is the radius of the scanning circle in all experiments. All images presented in this paper were obtained on a single plane. The scanning plane could be adjusted along the z axis to guarantee coverage of the nanoparticle samples or tumor by mounting the rotator and the transducer on a platform driven by a linear stage. The acoustic transducer was immersed in the water tank while the phantoms/mice were placed at the center of the tank where it was illuminated by the laser. The complex wave-field signal was amplified by a pulser/receiver (GE Panametrics, Waltham, MA) and was then acquired by a high-speed PCI data acquisition board. The data collection for the single plane took about 4 min.
In separate experiments, photoacoustic measurements were made by collecting the data from the tumor region only following intravenous injection of PEGylated gold nanoparticles (50 nm). For these experiments, the ultrasound transducer was placed in direct contact with the side of the tumor while the tumor was exposed to the pulsed laser.
PAT images were reconstructed by our reconstruction algorithm, which is based on the finite element solution to the photoacoustic wave equation in the frequency domain, which can provide stable inverse solutions [10] . The following is a brief description of this approach.
Time harmonic light-induced acoustic wave propagation in tissue can be described by a Helmholtz-like equation [22] 
where p is the pressure wave; k 0 is the wavenumber; c 0 is the speed of the acoustic wave in the medium; β is the thermal expansion coefficient; C p is the heat capacity at constant pressure; Φ is the product of the optical absorption coefficient and the excitation light distribution. To solve equation (1) with the finite element method, the matrix equations capable of inverse solution can be stated as
where the elements of the matrix A and b are expressed as
o and p c in equation (3) are the vectors representing the observed and computed complex acoustic field data at the boundary locations, respectively.
is the Jacobian matrix formed by ∂ p/∂ at the boundary measurement sites, χ is the update vector for the optical properties, λ is a scalar and I is the identity matrix. Based on iterative solutions of equations (2) and (3), the optical absorption distribution is updated in order to minimize the weighted sum of the squared difference between computed and measured data so that PAT images are reconstructed. All the PA images presented in this paper were reconstructed by employing a dual-meshing method in the algorithm for efficient inverse computation, in which a coarse mesh with 4500 nodes and a fine mesh with 18 000 nodes were used. The time for image reconstruction is about 8 h on a Pentium 4 PC with 1 GB memory.
Phantom experiments
Phantoms for imaging were constructed using 1% Intralipid, India Ink, distilled water and 2% agar powder as described previously [22, 23] . The diameters of all phantoms used in this study were 25 mm. The absorption and scattering coefficients (optical properties) of these phantoms were 0.007 mm −1 and 1.0 mm −1 at 532 nm, respectively. Nanoparticles and ex vivo organ (i.e. skin) were embedded in the phantom at a depth of 2 mm for imaging.
Animal experiments
All animal experiments were conducted under approved protocols from the University of Florida IACUC. All experiments were performed at least in triplicate and representative figures are shown in the paper. For subcutaneous imaging experiments, C57/BL6 mice were used. Mice were shaved prior to injection with particles. For tumor imaging experiments, human breast cancer cells, BT474 (ATCC) were implanted on the lower abdominal wall of Nu/Nu mice and allowed to grow to ∼1.0 cm in size. During imaging experiments, mice were anesthetized using pentobarbital. Anesthetized mice were fixed on a frame made of transparent Plexiglas at an angle of 30
• to the horizontal by using a soft fiber. A concave square was designed in the bottom of the water tank to hold the base of the frame so that in each experiment the frame could be placed at the exactly same position. The head of the mouse was above the water while the lower part of its body was submerged in the water.
Results and discussion
The gold nanoparticles were prepared by the citrate reduction of the gold ions. The particles size as determined by the CPS disc centrifuge method was determined to be ∼52 and ∼20 nm with a polydispersity index of 1.08. Particle size and morphology were also determined by TEM. Figure 1(a) shows the representative TEM picture of the 50 nm gold nanoparticles.
The particle size of gold nanoparticles, determined again after performing the PEGylation reaction, did not show any significant variation.
Ex vivo experiments were initially performed to reveal the light-induced acoustic signal generated by the mouse skin and gold nanoparticles. Twenty nanometer gold nanoparticles and 50 nm gold nanoparticles with a concentration of 5.0 × 
10
11 ml −1 , estimated by UV-vis absorption spectra [24] , were used for these experiments. The absorption coefficients of these nanoparticles are high at 532 nm, which are 0.018 mm −1 and 0.025 mm −1 for 20 nm and 50 nm particles, respectively ( figure 1(b) ).
A 5 mm × 4 mm sample of skin that was harvested from the abdomen of an anesthetized mouse was embedded in the left side of the phantom while 5 μl of 50 nm nanoparticles were put into a hole of 1.4 mm diameter that was located on the right side of the phantom (figure 2). These objects were then covered with a 2 mm thick layer of phantom. Figure 2 demonstrates a photograph of the phantom with phantom cover removed and the corresponding reconstructed PAT image. Both skin and 50 nm nanoparticles generated acoustic signals when they were illuminated by a pulsed laser beam and their PAT images are clearly recovered. The reconstructed sizes of skin and nanoparticles were 5 mm × 3 mm and 2 mm × 2 mm, respectively, which were very close to their actual sizes. In the two object regions we calculated the average of the reconstructed optical absorption and obtained 1.6 and 0.50 (arbitrary units) for nanoparticles and skin, respectively. Thus, the photoacoustic contrast between 50 nm nanoparticles and skin was approximately 3.2.
To determine the effect of the presence of nanoparticles in the skin tissue on PAT, mouse skin following injection with gold nanoparticles was harvested and implanted in a phantom for photoacoustic scanning. Figure 3(a) shows a photograph of mouse skin, with 25 μl of 50 nm nanoparticles injected in the center. The corresponding PAT image is shown in figure 3(b) . The approximate shape of the skin was evident. At the center part of the skin the average optical absorption was 0.70 while that of the skin region without nanoparticles was 0.40. A contrast of 1.8 was thus obtained between the skin regions with and without 50 nm nanoparticles.
In vivo photoacoustic imaging experiments were performed before and after the injection of 20 and 50 nm gold nanoparticles into the subcutaneous abdominal wall of the mice. A similar volume of saline was injected in mice for conducting control experiments. Photographic and PAT image subtractions for 50 nm and 20 nm nanoparticles' cases are shown in figures 4(a) and (b) and figures 4(c) and (d), respectively. The result of a control case, in which the saline was injected instead of nanoparticles, is displayed in figures 4(e) and (f). Figures 4(b) , (d) and (f) were obtained by subtracting the PAT image before injection from that after injection, thus revealing the change of PAT images that was introduced by the injected solution. From the PAT images, it is clear that both 20 nm particles and 50 nm particles were imaged in vivo with excellent contrast. A direct comparison between 20 and 50 nm particles in vivo is difficult as multiple factors including intratumoral distribution of particles, delivery, metabolism and depth of injection all contribute to observed signal intensity [25] . For the saline control case, changes of absorption were very small and disorderly (random) in the whole image region and can be taken for noise between the two scans.
The ability of the gold nanoparticles to serve as contrast agents for in vivo tumor imaging with PAT was determined by administering PEGylated gold nanoparticles (50 nm) (200 μl, 10 mg ml −1 ) via tail vein in the breast cancer tumor model. Serial photoacoustic images were made of tumors following systemic administration of gold nanoparticles. The accumulation of untargeted PEGylated nanoparticles inside tumors following systemic administration is expected and has been demonstrated to occur via an 'enhanced permeability and retention' (EPR) effect [26, 27] . Figure 5 shows various PAT images post-tail vein injections. The accumulation of gold nanoparticles inside tumors can be visualized by PAT and is observed clearly 5 h following systemic administration of gold nanoparticles ( figure 5(b) ). In order to further characterize the accumulation of gold nanoparticles (50 nm) in tumors following intravenous administration to tumor-bearing mice, focused photoacoustic experiments were performed in which the ultrasound transducer was placed in contact with the tumor concurrent with exposure of the tumor to pulsed laser light. These experiments were designed to more directly characterize intratumoral changes in photoacoustic signaling following intravenous administration of nanoparticles to tumor-bearing mice. An increase in photoacoustic signaling was seen in gold nanoparticle-treated tumor-bearing mice compared to control saline-injected mice (figure 6) consistent with PAT findings. PAT imaging thus provides a unique non-invasive imaging tool to quantitatively determine the presence of light absorbing nanoparticles in biological systems and exploit them for diagnostic and therapeutic applications.
PAT has been demonstrated to effectively image millimeter-sized objects containing gold nanoparticles in phantom gels [10] . Further, PAT has been used to clearly image ex vivo chicken bones in gel phantoms [23] . The potential to use photoacoustic tomography for imaging of structures in living organisms has been raised by several groups [9, 28] . Photoacoustic tomography has been used to image other gold nanostructures to a depth of 6 cm in experiments utilizing gelatin phantoms using NIR light [9] . Ku et al [28] have used PAT with near-infrared pulses at 800 nm, and indocyanine green as a contrast agent, to image objects ex vivo embedded in chicken breast muscle. The present study demonstrates for the first time that gold nanoparticles may be used as a contrast agent for in vivo tumor imaging with finiteelement-based PAT. A direct comparison between the contrast generated by gold nanoparticles utilized in these studies and other NIR absorbing nanoparticles is not possible given their differences in absorption profiles. Gold nanoparticles as used here could not be imaged with NIR-based PAT as has been used for the other NIR absorbing nanoparticles. Gobin et al have imaged tumors in vivo using non-targeted nanoshells with optical coherence tomography [29] . PAT, as demonstrated here, may be used to quantitatively analyze gold nanoparticle accumulation in tumors. The minimum quantity of gold nanoparticles needed for in vivo imaging has not been determined in these experiments but is highly dependent on particle chemistry and size, host biology, route of delivery and tumor targeting strategies. Understanding these dynamic interactions related to contrast agent delivery and conspicuity are areas of our ongoing research effort. In addition, the impact of subtle changes in particle shape on photoacoustic signaling has not been investigated in the present study but may be worthy of further investigation.
Others have similarly demonstrated the preferential accumulation of untargeted PEGylated nanoparticles in tumors in vivo following systemic administration via the EPR effect [27, 29, 30] .
Biological targeting of gold nanoparticles [31] to cancer cells may further increase the magnitude or change the pattern of accumulation of gold nanoparticles inside tumors. This could be well studied to using photoacoustic tomography [32] as demonstrated here. The ability to image gold nanoparticle inside tumors with PAT also suggests an opportunity for image guided cancer therapy with gold nanoparticles serving as tumor imaging contrast agents and mediators of cancer therapy [4] . The presently employed laser system (532 nm) for PAT used in conjunction with gold nanoparticles as a contrast agent has the potential to allow for non-invasive early diagnosis and image guided treatment of superficial, often refractory, tumors such as malignant melanoma, squamous cell carcinoma and Merkel cell carcinoma.
